Quantitative systems pharmacology model‐based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3‐kinase inhibitors
Abstract Several PI3K inhibitors are in clinical development for the treatment of various forms of cancers, including pan‐PI3K inhibitors targeting all four PI3K isoforms (α, β, γ, and δ), and isoform‐selective inhibitors. Diarrhea and immune‐mediated colitis are among the adverse events observed wi...
Main Authors: | Kapil Gadkar, Christina Friedrich, Vincent Hurez, Maria‐Luisa Ruiz, Leslie Dickmann, Mohit Kumar Jolly, Leah Schutt, Jin Jin, Joseph A. Ware, Saroja Ramanujan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12749 |
Similar Items
-
Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach
by: Kapil Gadkar, et al.
Published: (2016-01-01) -
gQSPSim: A SimBiology‐Based GUI for Standardized QSP Model Development and Application
by: Iraj Hosseini, et al.
Published: (2020-03-01) -
A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models
by: Saroja Ramanujan, et al.
Published: (2019-06-01) -
Therapeutic Potency of PI3K Pharmacological Inhibitors of Gastrointestinal Cancer
by: Kamelia Hashemzadeh, et al.
Published: (2019-01-01) -
A Mechanistic Systems Pharmacology Model for Prediction of LDL Cholesterol Lowering by PCSK9 Antagonism in Human Dyslipidemic Populations
by: K Gadkar, et al.
Published: (2014-11-01)